STOCK TITAN

Cohen & Steers (CNS) Financials

CNS NYSE
FY2025 annual
Revenue $556.1M +7.5% YoY
Net Income $153.2M +1.3% YoY
EPS (Diluted) $2.97 0.0% YoY
Free Cash Flow -$126.4M -248.7% YoY
Market Cap $3.3B as of Nov 20, 2026
Price / Sales 5.5x on $599.6M revenue, trailing 12 months to September 30, 2026
Price / Earnings 19.5x on $168.8M net income, trailing 12 months to September 30, 2026
Price / Book 5.4x on $607.7M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CNS SEC filings page.

Cohen & Steers Inc. (CNS) reported $556.1M in revenue for fiscal year 2025, up 7.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CNS FY2025

Cohen & Steers remains profitable and asset-light, but FY2025 exposed a sharp disconnect between accounting earnings and operating cash generation.

Operating cash flow swung from $96.7M in FY2024 to -$120.4M in FY2025 even as reported net income increased. That reverses cash conversion from 63.9% of net income to -78.6%, making the year's earnings look much stronger on the income statement than in cash terms.

Revenue grew 7.5% while operating income grew only 2.8%, so additional sales generated proportionally less operating profit. SG&A rose 18.5% as operating margin fell 1.5 percentage points, indicating cost growth limited the benefit of higher revenue.

Free cash flow reached -$126.4M despite capital expenditures at only 1.1% of revenue, so the cash shortfall was not primarily reinvestment. Meanwhile, liabilities were 27.7% of assets versus 29.2% in FY2024, indicating a less liability-dependent balance sheet even as cash generation weakened.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 57 / 100
Financial Health Score (4 of 6 dimensions) 57/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cohen & Steers Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
91

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Cohen & Steers Inc. scores 91/100 on it among other operating companies.

Growth
55

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Cohen & Steers Inc. scores 55/100 on it among other operating companies.

Leverage
60

Cohen & Steers Inc. carried $0.43 of total liabilities for every $1 of shareholders' equity at the end of fiscal year 2025. With no long-term debt figure for fiscal year 2025, Cohen & Steers Inc. is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 60/100 among other operating companies measured the same way.

Liquidity
n/a

Not available for Cohen & Steers Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Cash Flow
23

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Cohen & Steers Inc. scores 23/100 on it among other operating companies.

Returns
n/a

Not available for Cohen & Steers Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Piotroski F-Score Partial
1/6

Cohen & Steers Inc. passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Cohen & Steers Inc. used $0.79 of operating cash (-$120.4M OCF vs $153.2M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$157.4M
YoY+11.1%
QoQ+3.1%
5Y CAGR+0.4%
10Y CAGR+5.2%

Cohen & Steers Inc. generated $157.4M in revenue in Q3 2026. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is up 3.1%.

EBITDA
$53.7M
YoY+4.5%
QoQ-3.0%
5Y CAGR-4.9%

Cohen & Steers Inc.'s EBITDA was $53.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.5% from the same quarter a year earlier. Against the prior quarter it is down 3.0%.

Net Income
$42.2M
YoY+1.3%
QoQ-14.4%
5Y CAGR-3.9%
10Y CAGR+5.9%

Cohen & Steers Inc. reported $42.2M in net income in Q3 2026. This represents an increase of 1.3% from the same quarter a year earlier. Against the prior quarter it is down 14.4%.

EPS (Diluted)
$0.81
YoY0.0%
QoQ-14.7%
5Y CAGR-5.1%
10Y CAGR+4.7%

Cohen & Steers Inc. earned $0.81 per diluted share (EPS) in Q3 2026. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 14.7%.

Cash & Balance Sheet

Free Cash Flow
$20.0M
YoY-62.0%

Cohen & Steers Inc. generated $20.0M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 62.0% from the same quarter a year earlier.

Cash & Debt
$66.1M
YoY-32.6%
QoQ+11.8%
5Y CAGR-17.1%
10Y CAGR-8.6%

Cohen & Steers Inc. held $66.1M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Dividends Per Share
$0.67
YoY+8.1%
QoQ0.0%
5Y CAGR+8.3%
10Y CAGR+9.9%

Cohen & Steers Inc. paid $0.67 per share in dividends in Q3 2026. This represents an increase of 8.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
51M
YoY+0.8%
QoQ0.0%
5Y CAGR+1.3%
10Y CAGR+1.1%

Cohen & Steers Inc. had 51M shares outstanding in Q3 2026. This represents an increase of 0.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Operating Margin
32.4%
YoY-2.1pp
QoQ-2.1pp
5Y change-11.8pp
10Y change-7.0pp

Cohen & Steers Inc.'s operating margin was 32.4% in Q3 2026, reflecting core business profitability. This is down 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.1 percentage points.

Net Margin
26.8%
YoY-2.6pp
QoQ-5.5pp
5Y change-6.6pp
10Y change+1.5pp

Cohen & Steers Inc.'s net profit margin was 26.8% in Q3 2026, showing the share of revenue converted to profit. This is down 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.5 percentage points.

Return on Equity
7.0%
YoY-0.6pp
QoQ-1.4pp
5Y change-12.5pp
10Y change-1.8pp

Cohen & Steers Inc.'s quarterly ROE was 7.0% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks
$358K
YoY+38.8%
QoQ-9.1%
5Y CAGR+64.2%
10Y CAGR+13.3%

Cohen & Steers Inc. spent $358K on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 38.8% from the same quarter a year earlier. Against the prior quarter it is down 9.1%.

Capital Expenditures
$879K
YoY-64.7%

Cohen & Steers Inc. invested $879K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 64.7% from the same quarter a year earlier.

R&D Spending

Not reported for Q3 2026.

CNS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNS quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$157.4M+11.1%$152.7M+12.2%$145.6M+8.3%$143.8M+2.9%$141.7M+6.4%$136.1M+11.8%$134.5M+9.6%$139.8M+17.3%
SG&A Expenses$17.5M+4.5%$19.0M+4.8%$18.9M+10.1%$19.2M+21.7%$16.8M+12.8%$18.1M+23.1%$17.2M+16.1%$15.8M-8.8%
Operating Income$51.1M+4.4%$52.8M+21.8%$50.1M+10.9%$40.3M-18.3%$48.9M+9.0%$43.3M+12.8%$45.2M+12.3%$49.3M+30.3%
EBITDA$53.7M+4.5%$55.4M+21.2%$52.7M+10.8%$42.8M-17.2%$51.4M+8.9%$45.7M+12.4%$47.6M+11.8%$51.8M+31.6%
Income Tax$15.2M+8.9%$16.4M+36.4%N/AN/A$13.9M+13.3%$12.1M+10.9%N/A$12.7M+6.8%
Net Income$42.2M+1.3%$49.3M+33.9%$42.4M+6.5%$34.9M-23.9%$41.7M+5.2%$36.8M+16.0%$39.8M+17.0%$45.8M+53.7%
EPS (Basic)$0.82+1.2%$0.96+33.3%$0.82+5.1%$0.68-24.4%$0.81+3.8%$0.72+14.3%$0.78+13.0%$0.90+47.5%
EPS (Diluted)$0.810.0%$0.95+31.9%$0.82+6.5%$0.67-24.7%$0.81+5.2%$0.72+14.3%$0.77+13.2%$0.89+48.3%
Diluted Shares (Avg)52M+1.1%52M+0.8%52M+0.3%N/A52M+0.3%51M+1.4%51M+3.2%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense.

CNS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNS quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$979.8M+22.2%$901.0M+20.0%$854.7M+2.4%$876.7M+7.9%$801.6M+10.1%$751.0M-4.2%$834.9M+22.6%$812.4M+10.3%
Cash & Equivalents$66.1M-32.6%$59.2M-38.0%$53.1M-18.6%$145.5M-20.5%$98.1M-7.9%$95.4M-21.8%$65.2M-34.5%$183.0M-2.4%
Accounts ReceivableN/AN/AN/AN/A$68.3MN/AN/A$74.4M
GoodwillN/AN/AN/A$18.8M+7.3%N/AN/AN/A$17.5M-3.5%
Total Liabilities$231.1M+3.9%$205.6M-1.5%$187.8M-3.0%$242.8M+2.3%$222.4M+3.3%$208.7M+4.5%$193.5M-6.0%$237.5M-2.6%
Total Equity$607.7M+10.4%$589.4M+11.5%$563.4M+11.0%$562.0M+9.8%$550.3M+12.1%$528.5M+14.1%$507.7M+34.0%$511.7M+34.2%
Retained Earnings-$78.3Mn/m-$85.1Mn/m-$98.9Mn/m-$105.8Mn/m-$108.3Mn/m-$117.5Mn/m-$121.9Mn/m-$129.3Mn/m

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

CNS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNS quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$20.9M-62.1%$67.4Mn/m-$51.4Mn/m$1.1M-97.0%$55.1M+115.0%-$67.6M-315.6%-$108.9M-2340.3%$34.8M-40.5%
Depreciation & Amortization$2.7M+5.3%$2.6M+9.7%$2.6M+9.2%$2.5M+4.5%$2.5M+7.6%$2.4M+4.7%$2.4M+4.6%$2.4M+64.2%
Stock-Based CompensationN/AN/A$10.8M-5.1%N/AN/AN/A$11.4M-12.5%N/A
Capital Expenditures$879K-64.7%N/AN/A$282K-83.2%$2.5M+76.7%$2.1M-49.7%$1.1M-75.2%$1.7M-84.5%
Free Cash Flow$20.0M-62.0%N/AN/A$776K-97.7%$52.6M+117.2%-$69.8M-357.1%-$110.0M-20588.5%$33.1M-30.5%
Investing Cash Flow-$13.6Mn/m-$35.1M-1485.1%-$24.8M-1340.0%$39.1M+69.1%-$35.3Mn/m$2.5Mn/m$2.0Mn/m$23.1M+74.3%
Financing Cash Flow-$2.0Mn/m-$26.9M-128.7%-$13.7Mn/m$7.6M-42.1%-$17.0M-577.7%$93.8M+42.6%-$10.5Mn/m$13.1Mn/m
Dividends Paid$34.5M+8.8%$34.5M+8.9%$34.5M+8.9%$31.8M+5.9%$31.7M+5.9%$31.7M+6.1%$31.7M+8.2%$30.0M+6.8%
Share Buybacks$358K+38.8%$394K-36.6%$16.9M-34.9%$1.6M+1.3%$258K+279.4%$621K+363.4%$26.0M+34.2%$1.5M+79.5%

CNS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNS quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Margin32.4%-2.1pp34.5%+2.7pp34.4%+0.8pp28.0%-7.3pp34.5%+0.8pp31.8%+0.3pp33.6%+0.8pp35.3%+3.5pp
Net Margin26.8%-2.6pp32.3%+5.2pp29.1%-0.5pp24.3%-8.5pp29.4%-0.4pp27.1%+1.0pp29.6%+1.9pp32.8%+7.8pp
Return on Equity7.0%-0.6pp8.4%+1.4pp7.5%-0.3pp6.2%-2.7pp7.6%-0.5pp7.0%+0.1pp7.8%-1.1pp8.9%+1.1pp
Return on Assets4.3%-0.9pp5.5%+0.6pp5.0%+0.2pp4.0%-1.7pp5.2%-0.3pp4.9%+0.9pp4.8%-0.2pp5.6%+1.6pp
Liabilities-to-Equity0.380.0x0.350.0x0.330.0x0.430.0x0.400.0x0.390.0x0.38-0.2x0.46-0.2x
Asset Turnover0.160.0x0.170.0x0.170.0x0.160.0x0.180.0x0.180.0x0.160.0x0.170.0x
FCF Margin12.7%-24.4ppN/AN/A0.5%-23.2pp37.1%+18.9pp-51.2%-73.5pp-81.8%-82.3pp23.7%-16.3pp

Not reported in any period shown, so not listed: Gross Margin, Current Ratio, Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Cohen & Steers Inc. CNS FY2025 $556.1M $153.2M 27.6% $3.3B 57/100
Acadian Asset Management Inc. AAMI FY2025 $563.7M $80.0M 14.2% $2.8B 58/100
Golub Capital BDC, Inc. GBDC FY2026 $769.6M $95.5M 12.4% $3.2B 36/100
FS KKR Capital Corp. FSK FY2025 $1.5B $11.0M 0.7% $3.0B 19/100
AllianceBernstein Holding, L.P. AB FY2025 N/A $299.8M N/A $2.8B —
Blue Owl Technology Finance Corp. OTF FY2025 $1.1B $720.4M 62.9% $4.0B 67/100

Frequently Asked Questions

Cohen & Steers Inc. (CNS) reported $556.1M in total revenue for fiscal year 2025. This represents a 7.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Cohen & Steers Inc. (CNS) revenue grew by 7.5% year-over-year, from $517.4M to $556.1M in fiscal year 2025.

Yes, Cohen & Steers Inc. (CNS) reported a net income of $153.2M in fiscal year 2025, with a net profit margin of 27.6%.

Cohen & Steers Inc. (CNS) reported diluted earnings per share of $2.97 for fiscal year 2025. That is unchanged from the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cohen & Steers Inc. (CNS) had EBITDA of $187.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Cohen & Steers Inc. (CNS) had an operating margin of 32.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Cohen & Steers Inc. (CNS) had a net profit margin of 27.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Cohen & Steers Inc. (CNS) paid $2.48 per share in dividends during fiscal year 2025.

Cohen & Steers Inc. (CNS) has a return on equity of 27.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Cohen & Steers Inc. (CNS) recorded an outflow of $126.4M in free cash flow during fiscal year 2025. This represents a -248.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Cohen & Steers Inc. (CNS) recorded an outflow of $120.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Cohen & Steers Inc. (CNS) had $876.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Cohen & Steers Inc. (CNS) invested $6.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Cohen & Steers Inc. (CNS) spent $28.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Cohen & Steers Inc. (CNS) had 51M shares outstanding as of fiscal year 2025.

Cohen & Steers Inc. (CNS) had a liabilities-to-equity ratio of 0.43 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Cohen & Steers Inc. (CNS) had a return on assets of 17.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Cohen & Steers Inc. (CNS) trades at 19.5x earnings, its market capitalization divided by $168.8M net income, trailing 12 months to September 30, 2026. The market capitalization is $3.3B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cohen & Steers Inc. (CNS) trades at 5.5x sales, its market capitalization divided by $599.6M revenue, trailing 12 months to September 30, 2026. The market capitalization is $3.3B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cohen & Steers Inc. (CNS) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Cohen & Steers Inc. (CNS) used $0.79 of operating cash (-$120.4M OCF vs $153.2M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Cohen & Steers Inc. (CNS) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Cohen & Steers Inc. it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top